May 25, 2012 | last updated June 1, 2012 2:50 pm

CT's Alexion projects stock offer to net $462M

Cheshire drug maker Alexion Pharmaceuticals Inc. expects to net close to $462 million when its public offer of five million shares close right after Memorial Day, a regulatory filing shows.

Alexion priced the offering at $93.02 a share -- above its $92.41 a share in early trading Friday, according to its latest 8-K filing with the Securities and Exchange Commission.

The maker of Soliris for treating a rare and potentially fatal form of anemia said in the filing it expects to close the offering on or about Wednesday.

Proceeds will go to working capital and other general corporate purposes, the filing said.


Type your comment here:

Free E-Newsletters

Sign up now for our daily and weekly
e-newsletters! Click Here

Today's Poll
Most Popular on Facebook
Copyright 2017 New England Business Media